NYSE: BHVNBiohaven Ltd Stock Ownership - Who owns Biohaven?
Insider buying vs selling
Have Biohaven Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kimberly Gentile | SVP Clinical Operations | 2026-01-05 | 1,956 | $9.93 | $19.42kSell |
| Matthew Buten | Chief Financial Officer | 2026-01-05 | 2,594 | $9.93 | $25.76kSell |
| Bruce Car | Chief Scientific Officer | 2026-01-05 | 2,381 | $9.93 | $23.64kSell |
| George C. Clark | VP Chief Accounting Officer | 2026-01-05 | 1,117 | $9.93 | $11.09kSell |
| Vlad Coric | Chief Executive Officer | 2026-01-05 | 7,430 | $9.93 | $73.78kSell |
| George C. Clark | VP Chief Accounting Officer | 2025-11-17 | 17,000 | $8.52 | $144.77kBuy |
| Gregory Bailey | Director | 2025-11-13 | 400,000 | $7.50 | $3.00MBuy |
| Vlad Coric | Chief Executive Officer | 2025-11-13 | 333,333 | $7.50 | $2.50MBuy |
| Vlad Coric | Chief Executive Officer | 2025-11-13 | 333,333 | $7.50 | $2.50MBuy |
| John W. Childs | Director | 2025-11-13 | 3,333,333 | $7.50 | $25.00MBuy |
BHVN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BHVN insiders and whales buy or sell their stock.
BHVN Shareholders
What type of owners hold Biohaven Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John W. Childs | 10.35% | 15,564,580 | $148.33M | Insider |
| Suvretta Capital Management LLC | 6.84% | 10,286,937 | $98.03M | Institution |
| Stifel Financial Corp | 6.61% | 9,939,856 | $94.73M | Institution |
| Blackrock Inc | 6.28% | 9,448,040 | $90.04M | Institution |
| Infinitum Asset Management LLC | 4.16% | 6,250,000 | $59.56M | Institution |
| State Street Corp | 3.80% | 5,716,487 | $54.48M | Institution |
| Vlad Coric | 3.72% | 5,590,131 | $53.27M | Insider |
| Tcg Crossover Management LLC | 3.08% | 4,631,317 | $44.14M | Institution |
| Vanguard Group Inc | 2.92% | 4,395,946 | $41.89M | Institution |
| D E Shaw Co Inc | 1.79% | 2,694,234 | $25.68M | Institution |
BHVN vs Biotech Stocks
Biohaven Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.